Advancing Healthcare with Innovation & Quality | Trusted Pharma Solutions for a Healthier Tomorrow
Product Launch Announcement: Lenaliheal 25 (Lenalidomide 10mg) capsules We are proud to introduce Lenaliheal 25 contains Lenalidomide 25 mg, an oral immunomodulatory agent (IMiD®) used in the treatment of selected hematological malignancies. It is indicated for appropriate patients with conditions such as multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and certain types of lymphoma, in…
Product Launch Announcement: Lenaliheal 10 (Lenalidomide 10mg) capsules We are proud to introduce Lenaliheal 10 contains Lenalidomide 10 mg, an oral immunomodulatory agent (IMiD®) used in the treatment of selected hematological malignancies. It is indicated for appropriate patients with conditions such as multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and certain types of lymphoma, in…
Product Launch Announcement: Sutiheal 50 (Sunitinib Malate 50mg) Capsule We are proud to introduce Sutiheal 50 contains Sunitinib Malate 50 mg, an oral targeted anticancer therapy belonging to the multi-targeted tyrosine kinase inhibitor (TKI) class. It is indicated for the treatment of selected advanced cancers, including renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST) after failure…
Product Launch Announcement: Geftifine 250 (Gefitinib 250mg) Tablet We are proud to introduce Geftifine 250 contains Gefitinib 250 mg, an oral targeted anticancer therapy belonging to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class. It is indicated for the treatment of specific types of non-small cell lung cancer (NSCLC) with susceptible EGFR mutations,…
Product Launch Announcement: Palboheal 125 (Palbociclib 125mg) Capsule We are proud to introduce Palboheal 125, a premium formulation of Palbociclib 125mg capsules, developed to provide advanced targeted therapy in hormone receptor-positive breast cancer. Designed to support improved progression control, Palboheal 125 reflects our commitment to delivering innovative and reliable oncology solutions. 🔍 Product Overview Generic Name:…
Product Launch Announcement: Lenvaheal 4 (Lenvatinib 4mg) Capsule We are proud to introduce Lenvaheal 4 capsules is a targeted oral anticancer therapy containing Lenvatinib 4mg, designed to inhibit tumor growth and angiogenesis. It is widely used in the management of advanced and progressive cancers, offering a clinically proven option with precision-driven action. 🔍 Product Overview Generic…
Product Launch Announcement: Olanib 150 (Olaparib 150mg) Tablet We are proud to introduce Olanib 150, a high-quality formulation of Olaparib 150mg tablets, designed to provide targeted therapy in the management of specific BRCA-mutated cancers. Olanib 150 represents our commitment to delivering advanced oncology solutions that align with global treatment standards. 🔍 Product Overview Generic Name: Olaparib…
Product Launch Announcement: Anastrol 1 – Anastrozole 1mg tablet We are proud to introduce Anastrol 1, containing Anastrozole 1mg, a trusted and clinically proven aromatase inhibitor designed for the effective management of hormone receptor-positive breast cancer in postmenopausal women. 🔍 Product Overview Generic Name: Anastrozole Strength: 1mg Formulation: Tablet Primary Indications: Anastrol 1 – Anastrozole 1mg…
You really need to have a medicine safety checklist when you travel. This is a must for every traveller. A medicine safety checklist, for every traveller is very important. It can help you stay safe when you are travelling. Every traveller needs to have a medicine safety checklist. When you go on a trip it…
Most of us tend to drink water when winter comes. Our sweat is not much and we hardly ever feel like we need a drink. The chilly weather makes us desire to drink different things other than plain water. In fact, your body requires water in the winter just as it does in the summer….
End of content
End of content
WhatsApp us
